Ramot B, Levanon M, Hahn Y, Lahat N, Moroz C
Clin Exp Immunol. 1977 Mar;27(3):440-5.
Biosynthetic studies in alpha-heavy chain disease were performed on the gut tumour which was composed mainly of lymphoplasmocytic cells and on the mesenteric lymph node tumour composed mainly of immunoblasts. The gut tumour cells synthesised alpha-heavy chains and secreted them during 2-5 hr culture, whereas the lymph node tumour cells synthesized alpha-heavy chains which were shed into the culture medium only after 20 hr. These chains were shown to be present on the surface of the immunoblastic tumour cells by enzymatic radioiodination. Both the surface and the secreted alpha-heavy chain of the lymph node and gut tumour were found to be smaller than the alpha-heavy chain of myeloma proteins. These results suggest that the lymphoblasmocytic and the immunoblastic tumour cells originate from the same defective clone.
对主要由淋巴浆细胞构成的肠道肿瘤以及主要由免疫母细胞构成的肠系膜淋巴结肿瘤进行了α重链病的生物合成研究。肠道肿瘤细胞在2 - 5小时的培养过程中合成并分泌α重链,而淋巴结肿瘤细胞合成的α重链仅在20小时后才脱落到培养基中。通过酶促放射性碘化显示这些重链存在于免疫母细胞肿瘤细胞表面。发现淋巴结和肠道肿瘤的表面及分泌的α重链均比骨髓瘤蛋白的α重链小。这些结果表明淋巴母细胞性和免疫母细胞性肿瘤细胞起源于同一个有缺陷的克隆。